Drug Type Small molecule drug |
Synonyms HTS 09836, NB 001(Yongzhan Pharmaceutical), NB-001(Yongzhan Pharmaceutical) |
Target |
Action inhibitors, modulators |
Mechanism ADCY1 inhibitors(Brain adenylate cyclase 1 inhibitors), Cell membrane modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Molecular FormulaC12H20N6O |
InChIKeyCVPTTZZCRDVGSU-UHFFFAOYSA-N |
CAS Registry686301-48-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cancer Pain | Phase 1 | China | 08 Jul 2019 | |
Acute migraine | IND Approval | China | 28 Jul 2025 | |
Neuralgia | Preclinical | India | 12 Jan 2011 |